NCT03443089 - Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2017

Primary Completion Date

April 2, 2017

Study Completion Date

August 1, 2017

Conditions

Contraception

Interventions

DRUG

Test formulation

Administration of a single intramuscular dose of an injectable formulation containing medroxyprogesterone acetate 25 mg/mL + estradiol cypionate 5 mg/mL after an overnight fast.

DRUG

Reference formulation

Administration of a single intramuscular dose of an injectable formulation containing medroxyprogesterone acetate 25 mg/ampole + estradiol cypionate 5 mg/ampole after an overnight fast.

Trial Locations (1)

Unknown

Galeno Desenvolvimento de Pesquisas Clinicas Ltda. - ME, Campinas